Cargando…
Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity
Over two-thirds of the world's population lives in regions where rabies is endemic, resulting in over 15 million people receiving multi-dose post-exposure prophylaxis (PEP) and over 55,000 deaths per year globally. A major goal in rabies virus (RABV) research is to develop a single-dose PEP tha...
Autores principales: | Dorfmeier, Corin L., Tzvetkov, Evgeni P., Gatt, Anthony, McGettigan, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597479/ https://www.ncbi.nlm.nih.gov/pubmed/23516660 http://dx.doi.org/10.1371/journal.pntd.0002129 |
Ejemplares similares
-
ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo
por: Norton, James E., et al.
Publicado: (2014) -
Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses
por: Plummer, Joseph R., et al.
Publicado: (2019) -
Rabies virus glycoprotein as a carrier for anthrax protective antigen
por: Smith, Mary Ellen, et al.
Publicado: (2006) -
Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses
por: Lawrence, Tessa M., et al.
Publicado: (2013) -
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
por: McGettigan, Suzanne
Publicado: (2014)